Interleukin 23 Centres germinatifs ectopiques Thymoma Autoimmune diseases FMR1 Exercise Etiology Quality of life DICER Auto-immunité Genetic associations Cardiomyopathy Interferonopathy Gd T cells Immune response Interferon type I Innate immunity Chemokines Neuromuscular junction Early-onset myasthenia gravis COX2 PBMC Th17 cells MG patients CXCL13-CXCR5 Experimental mouse models Antimir-150 Complete Freund's adjuvant Interferon IFN Thymic epithelial cells Ferrites Glucocorticoids Autoimmune disease Germinal center Cellules th17 Myasthénie grave Myasthenia Gravis MG Thymectomy Inflammation Cell-cell communication Assay comparison Interféron de type I Follicular hyperplasia LMNA Genetics Il-23 B cells Chemokine Interferon Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Acetylcholine receptor BAFF Clinical cell transplantation Chronic inflammation Puberty Acetylcholine receptor antibodies Immunity Conduction disease CCL21 Experimental autoimmune myasthenia gravis Myoblasts Myasthenia Gravis Lamin A/C nuclei Gender Transcriptome Human myoblasts Autoimmunity CTCF Age Interferon-β CD31 Ectopic germinal centers Animal models Adaptive immunity Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Acetylcholine receptors Chronicity Interferon type-I Germinal centers Acides nucléiques endogènes Anticorps monoclonal Interferon de type I Fragile X syndromes COVID-19 Immunology and Microbiology Section Experimental autoimmune myasthenia gravis EAMG Heart failure Endogenous nucleic acids Immunotherapy Disease susceptibility M3243AG Myasthenia gravis Interleukine-23 Experimental models Cytokines Inflammatory cytokines AChR antibodies Immune regulation Long-term follow-up Thymus